Navigation Links
D1 Spas Unveils World's First Underwater Gym at IHRSA 2008
Date:3/7/2008

Award-winning Home Spa Company Taps World's #1 Aquatic Fitness Expert to Create Underwater Workout and Names Celebrity Fitness Guru as Spokesperson

for AFS

SAN DIEGO, March 7 /PRNewswire/ -- Dimension One Spas, the visionary and eco-savvy maker of luxury hot tubs sold worldwide, unveils its Aquatic Fitness System, the world's first underwater gym, at the International Health, Racquet & Sportsclub Association Conference in San Diego, March 6 through 8.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080306/LAF024)

Dimension One Spas is demonstrating its new "burn, tone and heal" AFS workout program, which was co-developed by the world's leading water fitness expert, Dr. Mary Sanders, Professor, University of Nevada's School of Medicine and Public Health, and Derek Duke Noble, noted author of The Body Noble and celebrity fitness trainer. The AFS underwater gym is being demonstrated at booth # 3454 on IHRSA's trade show floor at the San Diego Convention Center.

D1 Spas' revolutionary AFS is the ultimate hybrid of fitness and hydrotherapy that allows people of all ages and abilities to swim, walk, run, stretch, row, strength train, relax and heal in the comfort and convenience of their own homes. This watery workout is an ideal environment for low impact exercises to tone, shape and enhance flexibility, while the body is suspended in buoyant security. Offering twice the workout in half the time, the AFS is ideal for weekend warriors; hardcore triathaletes; aging boomers; overweight exercisers and athletes needing rehabilitation. D1 offers three models of the AFS -- the AquaFit 16, the AquaPro 19 and the AquaFit 19 Dual Temp -- and their retail price ranges from $29,995 to $44,995. http://www.AquaticFitnessSystems.com

The environmentally-friendly AFS is d
'/>"/>

SOURCE D1 Spas
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. VIDEO from Medialink and Philips: Philips Electronics Unveils First Imagination Light Canvas at the New Mercy Medical Center in Rogers AR
2. Centene Corporation Unveils Winners of the 2008 Physician Summit Award
3. Harris Corporation Unveils Broadcast-Style Multiviewers for Real-Time Multi- Screen Access to Medical Information
4. Meddius Unveils the Worlds Fastest Integration Appliance for the Healthcare Industry
5. Northwestern Memorial Hospitals Steven J. Stryker MD Unveils Campaign With Empower Public Relations
6. Aribex Unveils New Handheld Intraoral X-ray System - NOMAD Pro
7. High-End Treatment Center Moonview Sanctuary Unveils Four New Core Treatment Programs
8. iJET Unveils 2007 Year-in-Review Report on Avian Influenza and Pandemic Planning
9. LifeCare Hospitals of Wisconsin Unveils Center for Advanced Wound Healing
10. United Concordia Unveils New Online Capabilities for Producers
11. MedStar Health Unveils Rx for Success Program at Vivien T. Thomas Medical Arts Academy
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine Technology:Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 2Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 3Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 4Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 5Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 6